These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 12682624
1. Steroid myopathy in a child with juvenile rheumatoid arthritis. Case report. Genel F, Arslanoglu S, Hizarcioglu M, Durmaz B, Uran N, Aktaş S. Panminerva Med; 2003 Mar; 45(1):75-7. PubMed ID: 12682624 [Abstract] [Full Text] [Related]
2. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J. J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453 [Abstract] [Full Text] [Related]
3. Methotrexate in juvenile idiopathic arthritis: answers and questions. Ravelli A, Martini A. J Rheumatol; 2000 Aug; 27(8):1830-3. PubMed ID: 10955319 [No Abstract] [Full Text] [Related]
4. Nodulosis in systemic onset juvenile idiopathic arthritis: an uncommon event with spontaneous resolution. Abdwani R, Scuccumarri R, Duffy K, Duffy CM. Pediatr Dermatol; 2009 Aug; 26(5):587-91. PubMed ID: 19840317 [Abstract] [Full Text] [Related]
5. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V. Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001 [Abstract] [Full Text] [Related]
6. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A. J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264 [Abstract] [Full Text] [Related]
8. Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment. Wang SJ, Yang YH, Lin YT, Yang CM, Chiang BL. Clin Rheumatol; 2002 Sep; 21(5):363-8. PubMed ID: 12223982 [Abstract] [Full Text] [Related]
9. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Eraso R, Gedalia A, Espinoza LR. J Rheumatol; 2002 May; 29(5):1104; author reply 1104-5. PubMed ID: 12022333 [No Abstract] [Full Text] [Related]
10. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H, German and Austrian Paediatric Rheumatology Collaborative Study Group. Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440 [Abstract] [Full Text] [Related]
11. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. Kimura Y, Pinho P, Walco G, Higgins G, Hummell D, Szer I, Henrickson M, Watcher S, Reiff A. J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633 [Abstract] [Full Text] [Related]
12. The German etanercept registry for treatment of juvenile idiopathic arthritis. Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, Hospach T, Huppertz HI, Keitzer R, Küster RM, Michels H, Moebius D, Rogalski B, Thon A, Paediatric Rheumatology Collaborative Group. Ann Rheum Dis; 2004 Dec; 63(12):1638-44. PubMed ID: 15115709 [Abstract] [Full Text] [Related]
13. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis. Riddle R, Ryser CN, Morton AA, Sampson JD, Browne RH, Punaro MG, Gatchel RJ. J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147 [Abstract] [Full Text] [Related]
14. [Drug treatment in juvenile chronic arthritis]. Goldenstein-Schainberg C, Yoshinari NH. Rev Hosp Clin Fac Med Sao Paulo; 1997 Apr; 52(2):90-5. PubMed ID: 9435402 [Abstract] [Full Text] [Related]
15. Histoplasmosis in a child with JRA on low-dose methotrexate. Hunstad DA, French AR. Rheumatology (Oxford); 2007 Jan; 46(1):177-8. PubMed ID: 17114804 [No Abstract] [Full Text] [Related]
16. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group. Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439 [Abstract] [Full Text] [Related]
17. Potential predisposition for nasal septal perforation with methotrexate use: report of 2 cases and literature review. Lee SL, Neskey D, Mouzakes J. Ear Nose Throat J; 2009 Aug; 88(8):E12-4. PubMed ID: 19688702 [Abstract] [Full Text] [Related]
18. [Juvenile idiopathic arthritis treated by methotrexate: result of treatment and tolerance]. Hajri R, Nasraoui R, Laatar A, Chekili S, Kassab S, Zakraoui L. Tunis Med; 2005 Mar; 83(3):137-42. PubMed ID: 15929440 [Abstract] [Full Text] [Related]
19. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J. Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313 [Abstract] [Full Text] [Related]
20. [Juvenile Still's disease: a case report of treatment with infliximab]. Meddeb N, Rammeh N, Gandoura N, Elleuch M, Cheour E, Sahli H, Hamza S, Maalej A, Sellami S. Therapie; 2002 Apr; 57(4):407-8. PubMed ID: 12422562 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]